Contraception

Episodes 1-13 of 13

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Jeffrey T. Jensen, MD, MPH

    Peer

  7

  

  RestartResume

  Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care

  RestartResume

  Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care

  0.25 credits

  Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care

  0.25 credits

• • 

    

    David L. Eisenberg, MD, MPH, FACOG

    Peer

  • 

    

    David J. Portman, MD

    Peer

  6

  

  RestartResume

  Contraception: Focus on Vaginal pH Modulation

  RestartResume

  Contraception: Focus on Vaginal pH Modulation

  0.25 credits

  Contraception: Focus on Vaginal pH Modulation

  0.25 credits

• • 

    

    Patricia Geraghty, MSN, FNP-BC, WHNP

    Peer

  • 

    

    Hugh S. Taylor, MD

    Peer

  9

  

  0.25 credits

  The Next Generation of Oral Contraception: Advances in Estrogens

  0.25 credits

• • 

    

    David L. Eisenberg, MD, MPH, FACOG

    Peer

  • 

    

    Patty Cason

    Peer

  • 

    

    David J. Portman, MD

    Peer

  11

  CME/CE Broadcast Replay

  

  RestartResume

  A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

  RestartResume

  A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

  1.00 credits

  A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

  1.00 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Barbara Dehn

    Peer

  12

  

  RestartResume

  Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

  RestartResume

  Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

  0.25 credits

  Reducing Estrogen Dosing in CHC: The Quest to Balance Safety with Tolerability

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Andrew M. Kaunitz, MD, FACOG

    Peer

  22

  

  RestartResume

  New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

  RestartResume

  New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

  0.25 credits

  New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Anita L. Nelson, MD

    Peer

  27

  

  RestartResume

  The Evolution of Estrogen in Contraception—From E1 to E4

  RestartResume

  The Evolution of Estrogen in Contraception—From E1 to E4

  0.25 credits

  The Evolution of Estrogen in Contraception—From E1 to E4

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    David J. Portman, MD

    Peer

  15

  

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch

  0.25 credits

  Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch

  0.25 credits

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Stephen M. Cohen, MD, FACOG

    Peer

  • 

    

    Sateria Venable

    Peer

  22

  CME/CE Broadcast Replay

  

  RestartResume

  New Directions in the Management of Uterine Fibroids

  RestartResume

  New Directions in the Management of Uterine Fibroids

  0.50 credits

  New Directions in the Management of Uterine Fibroids

  0.50 credits

• • 

    

    David J. Portman, MD

    Peer

  9

  CME/CE Broadcast Replay

  

  RestartResume

  The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions

  RestartResume

  The Changing Landscape of Contraceptive Trials: Recent Approvals and Future Directions

  0.50 credits

  The Changing Landscape of Contraceptive Trials: Recent Approvals and Future D...

  0.50 credits

• • 

    

    David J. Portman, MD

    Peer

  7

  

  0.25 credits

  The Creeping Pearl Index: Distinguishing Between Clinical Trial Efficacy and ...

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Thomas D. Kimble, MD

    Peer

  11

  

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives: The Creeping Pearl Index

  RestartResume

  Expanding Choices in Combined Hormonal Contraceptives: The Creeping Pearl Index

  0.25 credits

  Expanding Choices in Combined Hormonal Contraceptives: The Creeping Pearl Index

  0.25 credits

• • 

    

    Lee P. Shulman, MD, FACMG, FACOG

    Peer

  • 

    

    Kenneth J. Moise Jr., MD

    Peer

  11

  

  RestartResume

  Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management

  RestartResume

  Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagnosis and Management

  0.25 credits

  Hemolytic Disease of the Fetus and Newborn: Cutting Edge Strategies for Diagn...

  0.25 credits